Constant release rate solid oral dosage formulations of proprano

Details Constant release rate solid oral dosage formulations of proprano Constant release rate solid oral dosage formulations of proprano

1984-02-16

1985-06-11

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

424 22, A61K 922, A61K 926

Patent

active

045228043

ABSTRACT:
A constant order release rate solid oral dosage formulation of propranolol or a pharmaceutically acceptable salt thereof, said formulation comprising: a therapeutically effective amount of propranolol or a pharmaceutically acceptable salt; from about 0.5 to 6.0 weight percent of an acid-retardant or hydrophobic cellulose derivative; from about 2.5 to 35 weight percent of a hydrogenated vegetable oil: from about 1 to 20 weight percent of an acrylic acid polymer; from about 0.5 to 4.0 weight percent of fumed silicon dioxide and from about 0.4 to 3.0 percent of a lubricant.

REFERENCES:
patent: 3400197 (1968-09-01), Lippmann
patent: 3577514 (1971-05-01), Robinson
patent: 4138475 (1979-02-01), McAinsh et al.
patent: 4153677 (1979-05-01), John
patent: 4248856 (1981-02-01), Guley et al.
patent: 4248857 (1981-02-01), DeNeale et al.
patent: 4248858 (1981-02-01), Guley et al.
Zalani et al., C.A. 98, #149540g (1983) of Indian J. Pharm. Sci., 44(6): 129-131 (1982).
Roscoe et al., C.A. 97, #78789m (1982) of Biopharm. Drug Dispos. 3(2): 105-114 (1982).
Khanna et al., C.A. 94, #127301v (1981) of Indian Drugs 18(3): 103-108 (1980).
McAinsh et al., (II) C.A. 94, #214483z (1981) of Biopharm. Drug Dispos., 2(1): 39-48 (1981).
Jayaswal et al., (I) C.A. 93, #155800e (1980) of Aust. J. Pharm. Sci., 9(1): 22-26 (1980).
Jayaswal et al., (II) C.A. 92, #203511q (1980) of Indian Drugs 17(4): 102-107 (1980).
Olsson et al., C.A. 92, #64645w (1980) of Medd. Nor. Pharm. Selsk. 41(3): 29-36 (1979).
ICI Ltd., C.A. 89, #95008h (1978) of Belg. 859, 288, Mar. 30, 1978.

Affiliated with

Also associated with

Rating

Constant release rate solid oral dosage formulations of proprano does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Constant release rate solid oral dosage formulations of proprano, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Constant release rate solid oral dosage formulations of proprano will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1182460